- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 231/02 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
Patent holdings for IPC class C07D 231/02
Total number of patents in this class: 71
10-year publication summary
|
4
|
4
|
2
|
5
|
6
|
5
|
5
|
5
|
4
|
4
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Sharp & Dohme Corp. | 2189 |
5 |
| Novartis AG | 10612 |
4 |
| Celgene Corporation | 1403 |
4 |
| National Institute of Biological Sciences, Beijing | 100 |
3 |
| Northwestern University | 3457 |
2 |
| FMC Corporation | 834 |
2 |
| Verseon Corporation | 10 |
2 |
| Virginia Commonwealth University | 644 |
2 |
| Praxis Precision Medicines, Inc. | 194 |
2 |
| Nuvalent, Inc. | 77 |
2 |
| Merck Sharp & Dohme LLC | 3732 |
2 |
| Janssen Pharmaceutica N.V. | 3358 |
1 |
| Merck Patent GmbH | 5752 |
1 |
| Coley Pharmaceutical Group, Inc. | 32 |
1 |
| The Board of Trustees of the Leland Stanford Junior University | 6541 |
1 |
| The Regents of the University of Michigan | 4793 |
1 |
| Vertex Pharmaceuticals Incorporated | 1630 |
1 |
| Mayo Foundation for Medical Education and Research | 3295 |
1 |
| Apicore US LLC | 6 |
1 |
| Atomwise Inc. | 42 |
1 |
| Other owners | 32 |